Abstract
Neurological examination and myasthenia gravis (MG)-specific functional scales may not fully capture the psychological
and fatigue-related burden of MG. This cross-sectional registry-based study included 75 adults with
MG. Depressive and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and
Generalized Anxiety Disorder-7 (GAD-7) with validated Latvian- and Russian-language thresholds. Fatigue,
quality of life, functional impairment and clinical severity were assessed using the Fatigue Severity Scale
(FSS), 15-item Myasthenia Gravis Quality of Life Questionnaire (MG-QOL15), Myasthenia Gravis Activities
of Daily Living (MG-ADL) and MG Composite Score (MGCS). Analyses included group comparisons,
Spearman correlations, and exploratory multivariable linear regression. Positive depression and anxiety screens
were identified in 32/75 (42.7%) and 38/75 (50.7%) patients using language-specific thresholds, compared
with 25/75 (33.3%) and 18/75 (24.0%) using conventional thresholds, despite low-to-moderate disease activity
(median MGCS 3; MG-ADL 1). Depressive symptoms were associated with poorer MG-QOL15, higher
MGCS, greater functional impairment and higher anxiety scores, whereas anxiety correlated only weakly with
MG-QOL15 (rho = 0.270). Neurological severity alone may underestimate patient-perceived disease burden.
Depressive symptoms and fatigue contribute independently to MG-specific quality of life beyond conventional
clinical severity assessment, supporting psychological and fatigue screening even in patients with apparent
clinical stability.
and fatigue-related burden of MG. This cross-sectional registry-based study included 75 adults with
MG. Depressive and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and
Generalized Anxiety Disorder-7 (GAD-7) with validated Latvian- and Russian-language thresholds. Fatigue,
quality of life, functional impairment and clinical severity were assessed using the Fatigue Severity Scale
(FSS), 15-item Myasthenia Gravis Quality of Life Questionnaire (MG-QOL15), Myasthenia Gravis Activities
of Daily Living (MG-ADL) and MG Composite Score (MGCS). Analyses included group comparisons,
Spearman correlations, and exploratory multivariable linear regression. Positive depression and anxiety screens
were identified in 32/75 (42.7%) and 38/75 (50.7%) patients using language-specific thresholds, compared
with 25/75 (33.3%) and 18/75 (24.0%) using conventional thresholds, despite low-to-moderate disease activity
(median MGCS 3; MG-ADL 1). Depressive symptoms were associated with poorer MG-QOL15, higher
MGCS, greater functional impairment and higher anxiety scores, whereas anxiety correlated only weakly with
MG-QOL15 (rho = 0.270). Neurological severity alone may underestimate patient-perceived disease burden.
Depressive symptoms and fatigue contribute independently to MG-specific quality of life beyond conventional
clinical severity assessment, supporting psychological and fatigue screening even in patients with apparent
clinical stability.
| Original language | English |
|---|---|
| Journal | Scientific Reports |
| DOIs | |
| Publication status | Accepted/In press - 2026 |
Keywords*
- myasthenia gravis
- depression
- anxiety
- fatigue
- quality of life
Field of Science
- 3.2 Clinical medicine
Publication Type*
- 1.4. Reviewed scientific article published in Latvia or abroad in a scientific journal with an editorial board (including university editions)
Fingerprint
Dive into the research topics of 'Depressive symptoms and fatigue are independently associated with myasthenia gravis-specific quality of life beyond neurological severity: a cross-sectional study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver